100 Global View Drive
Warrendale
PA
15086
USA
724-940-6800
412-767-4120
Related Content
March 25, 2025 — Bayer plans to present data from 13 new analyses from across the KERENDIA (finerenone) comprehensive ...
March 25, 2025
March 17, 2025 — Bayer recently announced that the U.S. Food and Drug Administration (FDA) accepted its supplemental new ...
March 21, 2025
May 17, 2024 — The study design and baseline characteristics of FINE-HEART, a new prespecified, exploratory pooled ...
May 17, 2024
April 18, 2024 — Bayer AG and Asklepios BioPharmaceutical, Inc., a gene therapy company wholly owned and independently ...
April 18, 2024
March 29, 2020 — Patients with worsening heart failure and reduced ejection fraction who received the investigational ...
March 29, 2020
July 15, 2019 — The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic ...
July 15, 2019
September 12, 2017 — Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with ...
September 12, 2017
August 29, 2017 — The European Medicines Agency (EMA) issued a final opinion that recommended restricting the use of ...
August 29, 2017
July 5, 2017 — Bayer has enrolled the first patient in a global Phase IV study assessing the clinical effects of ...
July 05, 2017
Feature | Contrast Media| Dave Fornell
Here are several updates in medical imaging contrast media agents. Two of the biggest news items were related to safety ...
June 19, 2017